| Mridula Sood, MD | |
|
140 Academy St, Presque Isle, ME 04769-3102 | |
| (207) 764-3142 | |
| (207) 760-8170 |
| Full Name | Mridula Sood |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 25 Years |
| Location | 140 Academy St, Presque Isle, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699854117 | NPI | - | NPPES |
| 1699854117 | Medicaid | ME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD19354 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virginia Hospital Center | Arlington, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virginia Hospital Center Physician Group Llc | 8426231119 | 241 |
News Archive
Ceres, Inc., an agricultural biotechnology company, has been awarded a U.S. patent for a genetic sequence derived from soybean, covering uses of the gene in areas such as research, product development and plant transformation.
Center for Diagnostic Imaging (CDI) has opened a new outpatient imaging center in Waukesha's Westbrook Health Center, and has relocated all of its Delafield center services to this new location. The new center allows CDI to expand services to include high-field (1.5T) MRI, multi-slice CT as well as x-ray. In addition, there are plans of offering digital mammography and ultrasound services in early 2010.
OncoSec Medical Inc., a company developing the advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, announces it has established the University of California San Francisco (UCSF) as the second enrolling site for its Phase II Merkel cell carcinoma clinical trial (OMS-I110).
The drug Gleevec (imatinib mesylate) is well known not only for its effectiveness against chronic myeloid leukemia (CML) and acute lymphoblastic leukemia, but also for the story behinds its development. The drug was specifically designed to target an abnormal molecule-a fusion of two normal cell proteins-that fueled a tumor's growth.
A new international study shows that 5,000 foetuses in Europe annually are affected by spina bifida and other severe defects on the central nervous system. Seventy per cent of these pregnancies are terminated, while increased mortality and serious diseases affect the children who are born. At least half of the cases can be avoided by adding folic acid to staple foods as is already being done in seventy non-European countries.
› Verified 6 days ago
| Entity Name | Virginia Hospital Center Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144415480 PECOS PAC ID: 8426231119 Enrollment ID: O20110317000305 |
News Archive
Ceres, Inc., an agricultural biotechnology company, has been awarded a U.S. patent for a genetic sequence derived from soybean, covering uses of the gene in areas such as research, product development and plant transformation.
Center for Diagnostic Imaging (CDI) has opened a new outpatient imaging center in Waukesha's Westbrook Health Center, and has relocated all of its Delafield center services to this new location. The new center allows CDI to expand services to include high-field (1.5T) MRI, multi-slice CT as well as x-ray. In addition, there are plans of offering digital mammography and ultrasound services in early 2010.
OncoSec Medical Inc., a company developing the advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, announces it has established the University of California San Francisco (UCSF) as the second enrolling site for its Phase II Merkel cell carcinoma clinical trial (OMS-I110).
The drug Gleevec (imatinib mesylate) is well known not only for its effectiveness against chronic myeloid leukemia (CML) and acute lymphoblastic leukemia, but also for the story behinds its development. The drug was specifically designed to target an abnormal molecule-a fusion of two normal cell proteins-that fueled a tumor's growth.
A new international study shows that 5,000 foetuses in Europe annually are affected by spina bifida and other severe defects on the central nervous system. Seventy per cent of these pregnancies are terminated, while increased mortality and serious diseases affect the children who are born. At least half of the cases can be avoided by adding folic acid to staple foods as is already being done in seventy non-European countries.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mridula Sood, MD 140 Academy St, Presque Isle, ME 04769-3102 Ph: (207) 764-3142 | Mridula Sood, MD 140 Academy St, Presque Isle, ME 04769-3102 Ph: (207) 764-3142 |
News Archive
Ceres, Inc., an agricultural biotechnology company, has been awarded a U.S. patent for a genetic sequence derived from soybean, covering uses of the gene in areas such as research, product development and plant transformation.
Center for Diagnostic Imaging (CDI) has opened a new outpatient imaging center in Waukesha's Westbrook Health Center, and has relocated all of its Delafield center services to this new location. The new center allows CDI to expand services to include high-field (1.5T) MRI, multi-slice CT as well as x-ray. In addition, there are plans of offering digital mammography and ultrasound services in early 2010.
OncoSec Medical Inc., a company developing the advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, announces it has established the University of California San Francisco (UCSF) as the second enrolling site for its Phase II Merkel cell carcinoma clinical trial (OMS-I110).
The drug Gleevec (imatinib mesylate) is well known not only for its effectiveness against chronic myeloid leukemia (CML) and acute lymphoblastic leukemia, but also for the story behinds its development. The drug was specifically designed to target an abnormal molecule-a fusion of two normal cell proteins-that fueled a tumor's growth.
A new international study shows that 5,000 foetuses in Europe annually are affected by spina bifida and other severe defects on the central nervous system. Seventy per cent of these pregnancies are terminated, while increased mortality and serious diseases affect the children who are born. At least half of the cases can be avoided by adding folic acid to staple foods as is already being done in seventy non-European countries.
› Verified 6 days ago
Dr. Ronald Arthur Rohe, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 140 Academy St, Presque Isle, ME 04769 Phone: 207-764-5215 Fax: 207-768-4022 | |
Evgeny Kirsanov, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 140 Academy St, Presque Isle, ME 04769 Phone: 207-768-4000 | |
Dr. Thomas Buckingham, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 140 Academy St, Presque Isle, ME 04769 Phone: 207-764-1898 Fax: 207-764-6993 | |
Sherri Dumont, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 66 Spruce St Ste 4, Presque Isle, ME 04769 Phone: 207-769-2025 Fax: 207-764-0629 | |
Dr. Osama Aziz, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 146 Academy St, Suite 1b, The Aroostook Medical Center, Presque Isle, ME 04769 Phone: 207-764-2623 Fax: 207-764-6993 | |
Neeti Pokharel, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 140 Academy St, Presque Isle, ME 04769 Phone: 207-764-3142 Fax: 207-764-6459 | |
Haris Zaheer, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 140 Academy St, Presque Isle, ME 04769 Phone: 207-498-3476 Fax: 207-498-3534 |